Processa Pharmaceuticals Inc (PCSA)
2.475
-0.02
(-0.60%)
USD |
NASDAQ |
May 08, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Cash from Financing (Quarterly): -0.0306M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0306M |
| September 30, 2023 | -0.0527M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 6.352M |
| December 31, 2022 | -0.0536M |
| September 30, 2022 | -0.0352M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.30M |
| December 31, 2021 | 0.1314M |
| September 30, 2021 | -0.1852M |
| June 30, 2021 | -0.0231M |
| March 31, 2021 | 9.876M |
| December 31, 2020 | 17.37M |
| September 30, 2020 | -0.1564M |
| June 30, 2020 | 0.661M |
| March 31, 2020 | -0.0028M |
| December 31, 2019 | 0.8007M |
| September 30, 2019 | 0.5041M |
| June 30, 2019 | 0.2809M |
| March 31, 2019 | 0.115M |
| December 31, 2018 | -0.2193M |
| September 30, 2018 | 0.109M |
| June 30, 2018 | 2.734M |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | 2.098M |
| September 30, 2017 | 0.252M |
| June 30, 2017 | 0.075M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.015M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0471M |
| June 30, 2015 | 0.2499M |
| March 31, 2015 | 0.524M |
| December 31, 2014 | 0.4475M |
| September 30, 2014 | 0.566M |
| June 30, 2014 | 0.6677M |
| March 31, 2014 | 0.8935M |
| December 31, 2013 | -0.3465M |
| September 30, 2013 | 1.102M |
| June 30, 2013 | 0.9833M |
| March 31, 2013 | -0.0067M |
| December 31, 2012 | 0.2914M |
| September 30, 2012 | 0.162M |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.30M
Minimum
Mar 2022
17.37M
Maximum
Dec 2020
1.849M
Average
--
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.124M |
| Free Cash Flow | -8.066M |
| Free Cash Flow Per Share (Quarterly) | -1.508 |
| Free Cash Flow Yield | -248.6% |